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ABSTRACT

Abbas, Asma Abdullatif. M.S., Department of Microbiology and Immunology, Wright
State University, 2011. HSV-1 infection in keratinocyte cell lines treated with mitotic
inhibitors

The hypothesis for this research was: Herpes simplex virus type 1 (HSV-1)
infection of murine keratinocyte cell lines (HEL-30 and PAM-212) treated with mitotic
inhibitors leads to silencing of virus replication. At 0.1 (Multiplicity of infection) MOI,
PAM-212 keratinocytes showed some cell lysis and viral plaques were seen in HEL-30
keratinocyte cultures. PAM-212 keratinocytes, infected at 0.01 MOI, were more
susceptible to the lytic effect of HSV-1 than were HEL-30 cells.
In this study, 5-fluoro-2'-deoxyuridine (FUDR) treatment of both keratinocyte cell
lines permitted an increased survival of HSV-1- infected keratinocytes, especially for
PAM-212 cell line, which was further examined for the presence of sequestered virus
after treatment with FUDR and infection with HSV-1. In this post-mitotic state, HSV-1infected keratinocytes appeared to contain latent virus as suggested by the lack of virus
plaques or cytopathic effect (CPE). After infection, these cells were examined for the
presence of replicating HSV-1 in Vero cell overlays. Virus plaques were found,
suggesting that latency may have been established.
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INTRODUCTION

Herpes simplex virus type 1 (HSV-1) causes serious ocular disease that can lead
to blindness in both developed and underdeveloped countries (Liesegang, 2001). In spite
of a plethora of information concerning HSV-1 pathogenesis and latency, recurrent ocular
infections reactivated from virus latent in trigeminal nerve neuronal cells lead to eventual
loss of vision. Keratinocytes is chosen in this study because it is the primary site of
infection for HSV-1 and the infection occurs via an endocytic process (Nicola et al.,
2005). Frey et al. (2009) noted that both HSV-1 and interferon- gamma (IFN-γ) rendered
keratinocytes susceptible to the lytic effect of the virus and a concomitant increase in
expression of suppressor of cytokine signaling-1 (SOCS-1). To render the keratinocytes
susceptible to the antiviral action of interferon-gamma (IFN-γ) or its peptide mimetic and
protect from HSV-1-induced lysis, the keratinocytes were pretreated with either SOCS-1
small interfering RNA (siRNA) or a peptide antagonist of SOCS-1 (pJAk2). The SOCS-1
antagonist had both an antiviral effect against HSV-1 in the keratinocyte as well as a
synergistic effect on IFN-γ induction of an antiviral state. It was concluded that SOCS-1
plays an important role in the inhibition of the antiviral effect of IFN-γ in keratinocytes
infected with HSV-1(Frey et al., 2009). Because of this, Dr. Bigley (personal
communication) proposed that SOCS-1 antagonists could be used to abrogate this
refractoriness in vivo. Paradoxically, post-mitotic neuronal cells from the trigeminal
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ganglion of HSV-1-infected mice, in which HSV-1 lies latent, express high levels of
SOCS-1 in response to IFN-γ (Turnley et al., 2001) similar to that of keratinocytes (Frey
et al., 2009). The SOCS-1 peptide antagonist could permit reactivation of HSV-1
infection. To resolve this problem, responses of cultured neuronal cells to HSV-1 have to
be determined.
Neuro 2A cells are the only murine cell line available for studying the effect of
HSV-1 infection on neuronal cells. In our laboratory, Neuro 2A cells are not readily
grown to high numbers in cell culture.
The hypothesis for this study was: HSV-1 infection of murine keratinocyte
cell lines (HEL-30 and PAM-212) treated with mitotic inhibitors leads to silencing of
virus replication. In this post-mitotic state, we asked whether HSV-1 latency could be
established in the treated keratinocytes. HSV-1-infected keratinocytes appeared to
contain latent virus as suggested by the lack of virus plaques or cytopathic effect (CPE)
after infection. To demonstrate this result, keratinocytes were examined for the presence
of replicating HSV-1 in Vero cell overlays to rescue virus.
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LITERATURE REVIEW
HSV-1 Infection.
HSV-1 virus is dsDNA, a member of the alphaherpesvirus subfamily, which
causes an oral and ocular infection. In the primary infection, the virus enters the host
epithelial cells and then transfers from infected skin lesions or mucosal surfaces to the
neuronal cells in the trigeminal ganglion to establish a lifelong latency (figure 1A).
During the latent state, the virus inside the host cells can spread to other humans through
shed virions. The virus entry process is mediated by viral glycoproteins which are gB,
gC, gD, gH, and gL. These glycoproteins regulate the viral binding, viral entry, initial
infection (Spear, 2004), membrane fusion (Heldwein et al., 2006), and viral spread from
cell-to-cell (Akhtar and Shukla, 2009) (figure 1B).
HSV-1 latency.
HSV-1 is known to undergo a latency-reactivation cycle, the most important
feature for all the alphaherpesvirus members (De Regge et al., 2010). This cycle includes
three distinguishable steps: establishment of latency, maintenance of latency, and
reactivation from latency. These three steps are controlled by different transcription
factors such as latency associate transcripts (LAT), infected cell protein 0 (ICP0) and
infected cell protein 4 (ICP4).
LAT, which is the only transcript noticeable during latency (Avrin, 2007),
regulates all three stages (Perng et al, 2010). Moreover, Perng et al. (2000) showed that
LAT inhibits the apoptosis in cultured neuroblastoma cells (neuro 2A) by down
3

regulating major histocompatibility complex (MHC) (Perng et al., 2000). In addition to
LAT, the infected neuronal cells may express two of the immediate-early (IE) proteins
which are Infected Cell Polypeptide 0 and 4 (ICP0 and ICP4). ICP0 plays an important
role in controlling HSV-1 mRNA synthesis, latency, and replication (Liu et al., 2010),
while ICP4 regulates the transcription in both IE and late infection (Figure 2).

(A) (B)
Figure 1: Mechanisms of HSV-1 entry into host cells
(A) After attachment and membrane fusion, the nucleocapsid is transported into the
nucleus to release the viral DNA and then the transcription and the translation, followed
by assembly and release of the virus progeny. (B) gB, gC, gD, gH, and gL are
glycoproteins that play an important role in the virus entry and other processes. Adapted
from (Varki et al., 2009)
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ICP0
and
ICP4

LAT

Figure 2:- HSV-1 replication cycle and the viral proteins that are produced. ICP0
&ICP4 are immediate early gene while LAT is a late gene. Adapted from
(http://www.mdlab.com/html/research/rd_v_research.html)

Other immune elements related to herpes virus latency cycle include type I IFN (α
and β); these molecules appear within 1 hour after infection and play an important role in
controlling the viral infection. Moreover, IFN- α is expressed at higher levels in the
ganglion during latency (Carr et al., 1998). In addition, De Regge et al. (2010) using IFNα as treatment for TG neurons infected with HSV-1 induces a quiet HSV-1 infection state
that is similar to the latency condition. These results refer to the importance of the
latency-reactivation cycle (De Regge et al., 2010). Type 2 IFN is also known to have an
antiviral effect in the keratinocyte by inhibiting ICP0 which can stop the virus
reactivation process (Frey et al., 2009).
JAK/STAT pathway and IFN-

signaling.

Gamma interferon (IFN-γ, Type II interferon) is a cytokine that has an antiviral
effect against HSV-1. It is an important regulator for both innate and adaptive immunity.

5

It is secreted mostly by natural killer cells in the primary HSV-1 infection and T-cells
(CD8T cells and CD4T cells) in the secondary infection (Horvath C., 2004).
The Jak/STAT pathway is stimulated with cytokines such as IFN- . When IFNbinds to its receptor that consists of Interferon gamma receptor 1 (IFNGR1) and
Interferon gamma receptor 2 (IFNGR2), the binding stimulates protein kinases Jak1 and
Jak2 which phosphorylates the tyrosine residues on the receptor. This phosphorylation
will recruit STAT protein that binds to the phosphotyrosine complex. The
phosphorylated STAT dissociates from the receptor, dimerizes with another
phosphorylated STAT molecule and then migrates to the nucleus where it binds to the
IFN cytokine genes and activates gene transcription. In the case of herpes infection, IFN
is found in the trigeminal ganglia (TG) and plays a critical role in controlling the
infection by inhibition of reactivation and inhibition of ICP0 (Minami et al., 2002).

Figure 3:- The JAK-STAT pathway. Adapted from (Bruce et al., 2001-2005)
6

However, this pathway could be regulated by the inhibition of STAT1
phosphorylation using Suppressor of cytokine signaling-1 (SOCS-1) (DiGiandomenico et
al., 2009) which inhibits the antiviral activity of IFN-γ. SOCS-1 is inducible upon binding
of IFN-γ to its receptor on the cell surface. It contains kinase inhibitory region (KIR) that
binds to JAK2 tyrosine residue. This binding inhibits the autophosphorylation of STAT1
and then causes the inhibition of IFN-γ pathway.
The cellular responses to cytotoxic agents.
UV light, chemicals, and immune cells are considered cytotoxic agents that could
induce DNA damage. The cellular responses to this damage differs depending on its
severity, minor damage could just activate the cell cycle checkpoint and stimulate the
DNA repair pathways to cause cell survival. If the damage is severe, necrosis or
apoptosis will occur. (Figure 4)

Figure 4:- The cellular responses to cytotoxic agents. Adapted from (Fareed et al.,
2008).
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Procedure used to demonstrate virus latency.
Vierbuchen et al. (2010) were able to convert mouse fibroblasts into functional
neurons under the effect of three transcription factors (Ascl1, Brn2, and Myt1l). If it is
possible to induce herpes virus latency in keratinocytes, targets of initial HSV-1
infection, it may provide an experimental tool that could be manipulated to understand
the steps in latency development. As an initial step in this process toward mimicking the
naturally occurring HSV-1 latency in neuronal cells, keratinocytes (HEL-30 and PAM212) will be treated with nerve growth factor (NGF β) to stimulate cell proliferation, IFN
γ to protect the cells and inhibit HSV-1 infection (Minami et al., 2002), and mitotic
inhibitors (FUDR and Paclitaxel) to promote latency stage.
Latent infection is characterized by the absence of the virus and its antigens and
the presence of LAT, a single viral RNA (antisense to ICP0), which is considered as the
most important sign of latency. High levels of LAT lead to silencing the lytic gene
expression (Knipe and Cliff, 2008) and inhibition of apoptosis in the infected cells.
Enhancing cell proliferation through blocking the innate immunity and escaping the
adaptive one is another sign of virus latency especially if we are able to rescue the virus
using Vero cells. In addition to that, the extinction of viral gene expression, ICP0, will
denote virus inactivity.
Heterochromatin formation is also important in HSV-1 latency in which the viral
lytic gene expression is silenced by the assembly of the host cell chromatin on the viral
DNA. However, during lytic infection, the viral proteins facilitate the heterochromatin
dissociation (histone-viral lytic gene promoters). Knipe and Cliffe suggest that
heterochromatin formation influences the infectious state of HSV (lytic or a latent). They
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postulate that it is possible to find ways to cause an epigenetic switch to favor one state
on the other. Figure 5 shows their model for differentiation between lytic and latent
infection (Knipe and Cliffe, 2008) and a possible mechanism to exchange between lytic
and latent infection (Kutluay et al., 2009). The significance of this work is that it might
be possible to target latent viruses with agents that reduce heterochromatin (Knipe and
Cliffe, 2008). This present study is an initial attempt to convert a lytic infection to
latency in keratinocytes treated with mitotic inhibitors. If latency in these keratinocytes
cells can be proven, then the effect of the chromatin/heterochromatin state advocated by
Knipe and Cliffe for lytic and latent infections will be supported.

Figure 5: HSV-1 infection of epithelial cells and neurons. The difference
between lytic and latent infection and the role of ICP0 and LAT in the chromatin switch
adapted from (Knipe and Cliffe, 2008).
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These observations suggest that the appearance of heterochromatin in HSV
infection is an indicator of an unproductive infection while its absence is considered a
sign of productive infection (Knipe and Cliffe, 2008).
Using of mitotic inhibitors to promote latency in keratinocytes.
Anti-mitotic agents such as Paclitaxel (taxol) and 5-fluoro-2'-deoxyuridine
(FUDR) were used to render keratinocyte cell lines post-mitotic like neuronal cells.
Using purified chicken erythrocyte tubulin heterodimer Xiao et al. (2006 ) noted that
paclitaxel bound to β-tubulin in microtubules and enhanced structural stability of
microtubules which inhibits cellular replication in the transition from G0 to G1 phase
(metaphase and anaphase), S phase, and the mitotic phase (Figure 6A). This inhibition
may lead to mitotic arrest and apoptosis (Xiao at el., 2006). Moreover, Jordan and his
colleagues found that high concentrations of taxol (>100 nM) caused an increase in the
microtubular polymer mass and stimulated extensive bundle formation. However, low
concentrations of taxol significantly inhibit HeLa cells proliferation (Jordan et al, 1992,
1993, 1999). By blocking polmeraization, this suggests that paclitaxel inhibits all the
microtubul-dependent processes such as mitosis, migration, endocytosis and secretion
(Figure 6 B).
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(A)
Figure 5: (A) Paclitaxel acts as a mitotic inhibitor (Sonoda et al., 2003)

(B)
Figure 5 (B): Effect of taxol on the microtubules. The taxol inhibits the
depolymerization which stabilizes the microtubules. Adapted from (O'Day D., 1998)

In addition to paclitaxel, also referred to as Paclitaxel/taxol, FUDR also acts as a
mitotic inhibitor by inhibiting thymidylate synthase (TS) (Figure 6), which disrupts
deoxyribonucleoside triphosphate (dNTP) inside the cells. This would inhibit DNA
synthesis and mitosis, holds cells in S phase, and induces cell death (Kanzawa et al.,
1980).
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(Figure 7) FUDR is a mitotic inhibitor. It inhibits TS which leads to DNA damage.
Adapted from (Daniele F., 2001-2005)
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MATERIALS AND METHODS

Virus, cell lines and cell culture. HSV-1 (syn17+) (initially provided by Dr.
Nancy Sawtell, Children’s Hospital Medical Center, Cincinnati, OH) was titrated in Vero
cells (CCL-81, American Type Culture Collection). HEL-30 keratinocytes, derived from
C3H mice, (Dr. Janice Speshock, Wright Patterson Air Force Base) and PAM-212
keratinocytes, derived from BALB/c mice, (American Type Culture Collection), were
cultured in Dulbecco's Modified Eagle Medium (DMEM) (Fisher Science, Pittsburgh,
PA) supplemented with 10% bovine calf serum and 1µl/ml gentamicin sulfate solution.
The cells were grown on 100 mm2 tissue culture dishes were used to plate the cells which
were incubated in a humidified incubator at 37° C, 5% CO2, and 95% air.
Mitotic inhibitors. 5-Fluoro-2'-deoxyuridine (FUDR) (Fisher Scientific,
Pittsburgh, PA) and Paclitaxel (Taxol) (Fisher Science, Pittsburgh, PA) were used to
induce a post mitotic state in keratinocytes. FUDR was dissolved in 2% DMEM and a
stock solution of 1µg/ml was made. The stock was further diluted depending on the
experiment. Paclitaxel was dissolved in DMSO as 5µg/ml stock solution.
Cytopathic effect (CPE) assay. This assay was used to determine the effect of
HSV-1 treated with various concentrations of IFN- γ, FUDR, or Taxol or when FUDR or
Taxol were used with IFN- γ to treat HEL-30 or PAM-212 keratinocytes. Cells were
counted using a hemacytometer and plated in 96 well plates at densities of 2.0 x 10 4 to
3.0 x 10 4 per well; plates were incubated until the cells were 70-100% confluent. At that
13

point, cells were treated with different concentrations of mitotic inhibitors. Cells
were then incubated for various amounts of time depending on the experiment design
before infection with virus. Virus was removed two hours later and the plates incubated
for 48 h in DMEM supplemented with 10% FBC. The cells were rinsed with DMEM
after the end of each incubation period. Cells then were washed with phosphate-buffered
saline, pH 7.4 (PBS), fixed using 10% formalin and stained with 0.05% crystal violet.
Plates then were washed with H 2 O and dried overnight. Plates were scanned using a
ScanJet 5300C and the images examined using NIH image J to calculate the density of
cells in each well. These experiments were performed in triplicate and the results
analyzed statistically using SigmaPlot 11.2 (Systat Software, Inc., San Jose, CA)
Plaque assay. After treating cells with mitotic inhibitors and infecting them with
HSV-1, the virus was rescued by adding 1 X 10 5 Vero cells in DMEM containing 10%
CS and the 96-well culture plates incubated for 24 hours at 37o C in 5% CO2 ; plaques
were detected by methyl cellulose-containing overlay media (Fisher Science, Pittsburgh,
PA). The plates were stained with 0.02% crystal violet, scanned using an HP ScanJet
5300C, and the scans examined by Image J. The results were analyzed using SigmaPlot
11.2.
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RESULTS AND DISCUSSION
Selection of Dosages of Mitotic Inhibitors.
In preliminary titrations (data not shown), concentrations of FUDR above
10µg/ml were toxic to the keratinocyte cell lines. Titrations of FUDR from 160 to
2.5µg/ml were added to the keratinocytes. In Figure 8, concentrations of FUDR
160µg/ml, 80µg/ml, 10µg/ml, and 5µg/ml were used. After infection with HSV-1 at an
MOI of 0.1, fewer than 25% of HEL-30 cells survived these treatments. (p>0.001 by
ANOVA; * p= 0.004) (Figure 8).

Figure 8: the effect of high concentrations of FUDR on HEL-30. High concentrations
of FUDR induced cell death (*). For all subsequent experiments, concentrations of 510µg/ml of FUDR were used because each was non-toxic and inhibited replication of
virus. Note that the 0 bar denotes the viability in culture of untreated, uninfected cells.
15

Since Pushkarev and others found that high concentrations of paclitaxel led to cell
cycle arrest in G2/M phase (Pushkarev et al., 2009), an initial concentration of 5µg/ml
was added to keratinocytes for 30 min prior to HSV-1 infection.
Different HSV-1 MOI’s used to infect keratinocyte cell lines.
HEL-30 and PAM-212 keratinocytes were plated in 96 well plates and infected
with 0.01 or 0.1 MOI HSV-1 for 2 hours to permit adsorption of virus. The virus was
then removed and fluid replaced with DMEM containing 10% CS. The keratinocyte cell
lines were compared with Vero cells infected with these two MOI’s. In Figure 9, note
that at 0.1 MOI, each of the cell lines showed cytopathic effects; PAM-212 keratinocytes
and Vero cells showed cell lysis; and viral plaques which represented in the figure as
clear areas were seen in HEL-30 keratinocyte cultures. PAM-212 keratinocytes and Vero
cells, infected at 0.01 MOI, were more susceptible to the lytic effect of HSV-1 than were
HEL-30 cells which appeared as dark blue, stained areas with the lack of any clear spots.
These results were similar to those noted by Frey et al. (2009).
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Figure 9: cells response to 0.1 and 0.01 MOI of HSV-1. Vero cells, HEL-30, and
PAM-212 were infected with different MOI of HSV-1. Cells were stained with crystal
violet in 70% methanol. Arrows denote to the viral plaques.

The effect of IFN-γ on HEL-30 and PAM-212 keratinocytes.
As known that IFN- γ has an antiviral effect, we attempted to protect HEL-30 &
PAM-212 keratinocytes by treating them with different concentrations of IFN- γ. These
cells showed different response to IFN-γ treatment. The antiviral effect of IFN- γ was
greater in PAM-212 cells which showed about 40 folds increase in the cells viability with
the use of 100 unit, 25 folds with 75 units, and 10 folds with 50 units (Figure 10).
However, HEL-30 cells did not show much difference in the cell survival even with the
use of high concentrations of IFN- γ (20 folds with 100 and 10 folds with 75 units)
(Figure 11). Moreover, higher concentration of IFN-γ provided more protection as seen
by increased cell density.
17

Figure (10):- Effect of IFN-γ on HSV-1-infected PAM-212 keratinocytes. Cells were
treated with various concentrations of IFN-γ for 24h then infected with 0.01MOI HSV-1
for 2h. 24h after infection, we stained the cells and used image J to count the cells
viability. Error bars indicate standard error of the means. There were about a 40 fold
differences between cells treated with100 IFN-γ unit (*) and untreated, uninfected cells
(0) (p < 0.001). Note that the 0 bar denotes the viability in culture of untreated,
uninfected cells.
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Figure (11):- Effect of IFN-γ on HSV-1-infected HEL-30 keratinocytes. HEL-30 were
treated with various concentrations of IFN-γ for 24h then infected with 0.1 MOI of HSV1 for 2h. 24h after infection, the cells were stained and the images analyzed using the
Image J program to determine cell density (viability). Error bars indicate standard error of
the means. There were no significant differences between the viability of IFN-γ treated
cells and untreated, infected cells (0). The cell viability after treatment with 100ug/ml
IFN-γ increased 25-fold relative to virus infected cells (p < 0.001). None of the
differences among the HSV-1 infected cells are statistically significant. Note that the 0
bar denotes the viability in culture of untreated, uninfected cells.
These results mirror those observed by Frey et al for the PAM-212 keratinocytes
after infection with 0.1 MOI of HSV-1. A difference from the Frey study was seen for the
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HEL-30 cells in which approximately 20% of the keratinocytes survived HSV-1 infection
with 0.1 MOI of virus. In Frey’s study, none of the keratinocytes survived an MOI of 0.1.
This difference may reflect differences in the source of HEL-30 cells. The HEL-30 cells
in this study were derived from a stock received from Dr. J. Speshock, WPAFB, while
Frey’s were supplied by Dr. D. Germolec, National Institutes of Health.

The two mitotic inhibitors induce differences in the keratinocyte cell lines in a time
and concentration-dependent manner.
1. The effect of FUDR on HEL-30 and PAM-212 Keratinocytes.
Since FUDR acts as a mitotic inhibitor, we expected that the HSV-1 infection
would not cause a cell death for the FUDR-treated cells. FUDR treatment would
promote a cell proliferation. To determine the effect of FUDR on keratinocytes, cells
were treated with 100 units of IFN-γ for 24h, followed by exposure to either 10 or
5µg/ml FUDR before viral infection. The 5 µg/ml concentration permitted about 65
fold increase in PAM-212 cell viability comparing to untreated cells (Figure 12)
with less activity on HEL-30, (Figure 13). These variations in the response could
due to the fact that different keratinocytes differ in their susceptibility to HSV-1
infection.
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Figure 12:- The effect of FUDR on PAM-212 keratinocyte. PAM-212 keratinocytes
were plated in 96 well plate, and treated when they are about 80% confluence with 100
u/ml of INF-γ for 24h followed by 5 or 10µg/ml of FUDR treatment for an hour before
infection with the 0.01 MOI of HSV-1. There were statistically significant differences
between 100 u/ml IFN-γ and 5 µg/ml FUDR treated cells (*) and untreated, uninfected
cells (0) (p < 0.001). Note that the 0 bar denotes the viability in culture of untreated,
uninfected cells.
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*

Figure 13: The effect of FUDR on HEL-30 keratinocyte. HEL-30 keratinocytes were
plated in 96 well plates, and treated when they were about 80% confluence with
100µg/ml of IFN-γ for 24 hours. Then 5 µg/ml of FUDR was added for an hour, followed
by infection with the 0.1 MOI. There was a 25 fold difference between IFN-γ and FUDR
treated cells (*) and untreated, uninfected cells (0) (p = 0.013). Note that the 0 bar
denotes the viability in culture of untreated, uninfected cells.

As shown in Figure 14, PAM-212 treated with FUDR maintains its cell
morphology and the percentage of growth. However, HEL-30 treated cells showed some
decrease in the rate of proliferation compared to untreated cells. Moreover, HEL-30 cells
formed more regular polygons.
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Figure 14: The effect of FUDR on PAM-212 and HEL-30 morphology and
proliferation. These photos were taken with a 10X objective lens.
2- The effect of paclitaxel on PAM-212 and HEL-30.
To examine the effect of paclitaxel on PAM-212 keratinocytes, cells were treated
with IFN-γ and paclitaxel before HSV-1 infection. PAM-212 treated cells showed 50
folds increase in the cell growth compared with untreated cells (Figure 15). To see if this
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effect were related to the paclitaxel or IFN- γ, the cells were treated with paclitaxel only.
As shown in figure 16, paclitaxel induced cell proliferation (20 folds increase) even in the
absence of IFN- γ. These results indicate that paclitaxel can inhibit the cell death caused
by HSV-1.

Figure 15:- the effect of Taxol on PAM-212keratinocytes. PAM-212 keratinocytes
were plated in 96 well plate, and treated when they are about 80% confluence with
100u/ml of IFN-γ for 24h followed by treatment with 5 µg/ml taxol for an hour before
infection with the virus at 0.1 MOI. There were statistically significant differences
between IFN-γ and FUDR treated cells (*) and untreated, uninfected cells (0) (p < 0.001).
Note that the 0 bar denotes the viability in culture of untreated, uninfected cells.
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Figure 16:- The effect of Taxol on PAM-212 keratinocytes without the IFN- γ treatment.
PAM-212 cells were treated with 5µg/ml of Taxol for 30 min before HSV-1 infection. Taxoltreatment provided a 20 fold increase (*), even in the absence of IFN-γ (p = <0.001). Note that

the 0 bar denotes the viability in culture of untreated, uninfected cells.
Because IFN-γ potentiated the lytic effect in HEL-30 cells at an MOI of 0.1 as
showed in figure 10, this cell line was not examined further following treatments with
paclitaxel and IFN-γ. As shown in figure 17, paclitaxel had a toxic effect on HEL-30
which appeared by the decrease of cell survival by 20 folds even in the absence of HSV1.

*

Figure 17:- The effect of paclitaxel/taxol on HEL-30 keratinocyte. HEL-30 keratinocytes were
plated in 96 well plates. When they were about 80% confluent, the cells were treated with 5µg/ml
of taxol for 30 min, followed by infection with the 0.1 MOI of HSV-1. Taxol treatment had a
toxic effect on HEL-30 cells (*) compared to untreated, uninfected cells (p = <0.001). Note that

the 0 bar denotes the viability in cultures of untreated, uninfected cells.
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In cultures of paclitaxel-treated keratinocytes, changes in the proliferation rate
and morphology were observed (Figure 18). These changes which were different
depending on the cell line were anticipated because paclitaxel causes microtubule's
alteration. HEL-30 cells were less susceptible to the anti-mitotic effect of paclitaxel than
were PAM-212 cells. This may be due to the reaction level between the cells and the
paclitaxel or any other treatments depending on the tumor type which is erythroleukemia
in HEL-30 and cutaneous squamous cells carcinoma in PAM-212 cell line. It also could
due to the variations in the degree of cell–cell contact formation, depending on cell
density in the culture dish (Schelhaas et al., 2003).
HEL-30 keratinocyte exhibited some changes in their morphology; these cells
were more rounded than untreated, uninfected cells and lost their plastic adhesion. These
observations were made microscopically 24 h after treatment, as well as 12 h and 16 h
after HSV-1 infection with an MOI of either 0.1.or 2.0 in which about 25%, 60%, 80%
respectively of cells were dead. Nevertheless, PAM-212 keratinocytes were much less
affected by the apoptotic effect and showed that they were more likely to go toward cell
cycle arrest (Figure 18). These results were comparable to results reported by Kim and
his colleagues' using different cell lines (Kim et al., 2001).
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Figure 18:- The effect of paclitaxel/taxol on PAM-212 and HEL-30 morphology and
proliferation. These photos were taken with a 10X objective lens
Attempt to rescue virus from FUDR-treated PAM-212 cells.
Knickelbein et al., (2008) overlayed single cell suspensions of trigeminal neuronal
cells with fibroblasts to rescue latent HSV-1 virions from the trigeminal neuronal cells.
Based on this observation, susceptible Vero cells were used to overlay the PAM-212 cell
cultures infected with HSV-1 in attempt to release the virus from PAM-212 cells (Figure
19). If the virus established latency inside HSV-1- infected, FUDR- treated PAM-212
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cells, we will have a decrease in the cell survival as a result of Vero cells overlay. Note
that viral plaque formation is apparent (marked with arrows) in the Vero cells overlayed
onto HSV-1- infected, FUDR- treated PAM-212 cells. An alternate explanation for this
observation may be that the virus exiting from the PAM-212 cells to infect the Vero cells
causes trauma to the PAM-212 cells. The staining of this set of wells was lighter and the
Vero cells overlay induced 40 fold decrease in the cell survival compared with the unoverlayed cells. These results suggest that the infected Vero cells may be releasing
enzymes which damaged the PAM-212 cells. Further experimentation is needed to
confirm that this viral infection reflects latency rather than surface contamination with
live virus. Polymerase chain reaction has to be done looking for LAT, which is the main
sign of latency.
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Figure 19: Effect of HSV-1 infection on FUDR-treated PAM-212 keratinocytes.
Triplicate samples of PAM-212 keratinocytes were treated with 5ug/ml FUDR for 1h and
then infected with 0.01 MOI HSV-1 for 2h. Virus was removed and plates were
incubated 24h then overlayed with Vero cells. 48h after infection, plates were stained
with 0.02% crystal violet, dried overnight and scanned and analyzed by using Image J
program and graphed with SigmaPlot 11.2. Fewer cells survived after Vero cells overlay
(*) compared to FUDR treated- HSV-1 infected cells (p= <0.001). Note that the 0 bar
denotes the viability in culture of untreated, uninfected cells.
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CONCLUSION AND FUTURE STUDIES
Primary infection, latent infection, and reactivation are the main stages that
characterized HSV-1. However, the stages leading to HSV-1 latency is still unclear. If it
is possible to develop a latent stage in keratinocytes, then it may be possible to dissect
these events to understand progression from initial infection to latency as seen in
neuronal cells. Since most of the antiviral drugs target the lytic state, targeting the virus
in the latent state is considered one of the new approaches for potential treatments. In this
study, two mitotic inhibitors were used to render the keratinocytes susceptible to a latent
HSV-1 infection.
In this study, FUDR treatment of both keratinocyte cell lines permitted an
increased survival of HSV-1- infected keratinocytes, especially for PAM-212
keratinocytes. This cell line was further examined for the presence of sequestered virus
after treatment with FUDR and infection with HSV-1. Knickelbein et al (2008) were able
to rescue HSV-1 from latency in murine trigeminal ganglia by co-culture with susceptible
fibroblasts. As shown in Figure 19, viral plaques were seen in PAM-212 cells 48 hour
after infection with HSV-1 and 24 hours after overlay with susceptible Vero cells
suggesting that this approach warrants further study. This study sets the stage for future
work in the laboratory confirming the usefulness of the latency model.
Further examination of the effect of FUDR on keratinocytes using different times
of exposure (2h, 4h, 6h, and 24h) is needed. Since Rich and his colleagues found that the
inhibitory effect of FUDR is reversible (Rich et al., 1958), HSV-1 infection of
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keratinocytes should be examined at different times after FUDR treatment. Paclitaxel
also was used as a mitotic inhibitor in these keratinocyte cells line in attempts to induce
viral latency. The concentration of paclitaxel used (5µg/ml) was toxic to both cell lines.
Since Choritz et al., (2010) found that the growth and migration inhibition resulted from
the exposure to paclitaxel/taxol is a dose and time dependent and lower concentrations of
paclitaxel induce less cell death, further investigation with lower concentrations of
paclitaxel (1µg/ml, 0.5 µg/ml, 0.01 µg/ml or lower) at different time of exposure is
needed to see if these low concentrations could induce a mitotic inhibition instead of cell
death.
In the latency process, silencing the lytic gene expression and blocking the host
cellular and humoral immune response have to be considered to achieve this goal. If
treatments of keratinocyte cell lines with these mitotic inhibitors render the cells
susceptible to herpes virus latency, expression of latency-associated transcript (LAT)
must be demonstrated in these cells. Future studies should include determining the
polymerase chain reaction products for early viral genes (ICP4 and ICP0) as well as
latent-associated transcript (LAT) in the keratinocyte when they are in the post mitotic
state. Initial attempts to demonstrate LAT in PAM-212 following treatment with FUDR
and HSV-1 infection were performed at 12 and 16 hours post infection. Since ICP0 and
ICP4 genes (immediate early, IE) are expressed early in infection time points of 5 and 16
hours post infection should be examined. ICP0 and ICP4 expression should predominate
in the 5hour samples and LAT, if present, should predominate in the 16 hour sample to
demonstrate latency. Future studies should include determining the polymerase chain
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reaction products for early viral genes (ICP4 and ICP0) as well as latent-associated
transcript (LAT) in the keratinocyte when they are in the post mitotic state.
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